Butaselen prevents hepatocarcinogenesis and progression through inhibiting thioredoxin reductase activity

Hepatocellular carcinoma (HCC) accounts for most of primary liver cancer, of which five-year survival rate remains low and chemoprevention has become a strategy to reduce disease burden of HCC. We aim to explore the in vivo chemopreventive effect of an organoselenium-containing compound butaselen (B...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Xiaoqing, Ma, Weiwei, Sun, Ruoxuan, Yin, Hanwei, Lin, Fei, Liu, Yuxi, Xu, Wei, Zeng, Huihui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5633849/
https://www.ncbi.nlm.nih.gov/pubmed/28965082
http://dx.doi.org/10.1016/j.redox.2017.09.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5633849/
https://www.ncbi.nlm.nih.gov/pubmed/28965082
http://dx.doi.org/10.1016/j.redox.2017.09.014

Ejemplares similares